Abstract
Dr. F. Peter Guengerich is a Professor of Biochemistry in the School of Medicine at Vanderbilt University. Born in Pekin, Illinois, in 1949, he received his BS from the University of Illinois in 1970. He then did his graduate work at Vanderbilt, receiving his PhD with Prof. H. P. Broquist in Biochemistry in 1973. After 2 years as a research fellow with Prof. M. J. Coon at the University of Michigan, he was hired as Assistant Professor of Biochemistry at Vanderbilt in 1975 and has been on faculty since then, having attained the rank of Professor in 1983. Prof. Guengerich has been Director of the Center in Molecular Toxicology, an interdepartmental program at Vanderbilt, since 1981. His own research laboratory deals with the chemical and biological mechanisms by which drugs and cancer-causing chemicals are processed and the relevance to drug development, toxicity, and disease. He is an author or coauthor of 483 original research articles and 122 invited reviews. He is or has been associate editor of 4 journals and on the editorial boards of 25. During the last decade (1993–2003; Institute for Scientific Information), his articles were cited by other biomedical scientists to rank him among the top 50 in the world in this overall category. Over the same period he is the third most-cited scientist in the area of Pharmacology and Toxicology. In 2001 he received the Earl Sutherland Research Prize, the highest research award given at Vanderbilt. He has also received a Distinguished Faculty Award (2003) and the Sidney Colowick Prize for Achievement in Research (2004) at Vanderbilt. He has also received research awards from a number of national and international scientific societies, including both the J. J. Abel (1984) and the B. B. Brodie (1992) Awards from the American Society for Pharmacology and Experimental Therapeutics, the Achievement Award (1982) and a Burroughs-Wellcome Toxicology Scholar Award (1983–1988) from the Society of Toxicology, the Kenneth Morgareidge Award (1986) from the International Life Sciences Institute, the Chemical Industry Institute of Toxicology Founders Award (1991), the George H. Scott Award from the Toxicology Forum (1994), the North American Scientific Achievement Award from the International Society for the Study of Xenobiotics (2003), and the 2004 Distinguished Service Award from the American College of Toxicology. In 2002 he received an honorary doctorate (Docteur Honoris Causa) from the University of Paris, V. More than 100 graduate students, research fellows, and visiting scientists from throughout the world have trained with him, and many of these individuals are now professors or hold important positions in the pharmaceutical industry. For these training efforts, he was the first recipient of the Vanderbilt School of Medicine Award for Training of Postdoctoral Fellows or Residents in the Research Setting (2000).